Clinical Pathways for Myeloid Growth Factors Lead to Appropriate Use
A poster presentation at AMCP Nexus 2017 found that the implementation of a clinical pathway increased the appropriate use of myeloid growth factors for patients receiving myelosuppressive cancer chemotherapy.
Novel Assay Enhances Targeted Treatment for DLBCL
A new gene expression profiling classifier can simultaneously evaluate the expression of 21 genetic markers, allowing for differentiation of three subtypes of diffuse large B-cell lymphoma.
Survey: Precision Medicine Program a “High Priority” in Oncology Health Care Systems
A recent survey has revealed that precision medicine programs are gaining ground as a critical investment within oncology health care systems.
DNA Mismatch Repair Status in Patients With Advanced Colon Cancer
A pooled analysis investigated the prognostic role of DNA mismatch repair status in patients with stage III colon cancer treated with a standard adjuvant chemotherapy regimen.
MS Guidelines Released for Disease-Modifying Therapy
The first guidelines on the use of disease-modifying therapies in multiple sclerosis have been issued by the European Committee for Research and Treatment of Multiple Sclerosis and the European Academy of Neurology.
Cost-Effectiveness Analysis Compares Multiple Therapy Options for Pretreated Multiple Myeloma
A recent study confirmed the most cost-effective treatment option in heavily pretreated patients with relapsed or refractory multiple myeloma.
